Stay updated on DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Sign up to get notified when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision tag updated to v3.3.4 and related topic tags including Multiple myeloma and MedlinePlus Genetics were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-14T01:17:58.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The related topics section now includes 'Multiple myeloma' and 'MedlinePlus Genetics' as related topics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-30T22:50:13.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added the Locations section with Attica, Greece (Athens site) to the study record. The revision note now shows Revision: v3.3.3, and older items like HHS Vulnerability Disclosure and Attica Locations were removed.
    Difference
    0.2%
    Check dated 2025-12-23T20:44:50.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page no longer references 'Multiple myeloma' and the related MedlinePlus Genetics topics, removing core disease context from the study details.
    Difference
    0.2%
    Check dated 2025-12-09T14:18:11.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:36:15.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Removed the government funding status notice and related operating-status details from the page. The related topics sections for 'Multiple Myeloma' and 'MedlinePlus Genetics' were also removed.
    Difference
    0.5%
    Check dated 2025-11-18T06:52:22.000Z thumbnail image

Stay in the know with updates to DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Enter your email address, and we'll notify you when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.